Christian Chabannon trained as a medical student at the University of Lyon, France. As a student, he was attracted to hematology, a medical field mixing biological and clinical activities and that has lead the field of diagnostic and therapeutic innovations for decades. He did his residency at the University of Grenoble, specializing in Hematology. At the end of his residency, he joined as a Research Associate the Transplantation Biology Program, part of the Clinical Research Division at the French Hutchinson Cancer Research Center in Seattle, WA, USA. Upon his return to France, he held a position of Assistant Professor at the Department of Hematology, Grenoble University Hospital. After two years, he moved to the Institut Paoli-Calmettes, the Comprehensive Cancer Center in France, to join the gene therapy program that had just started, and the Department of Clinical Oncohematology. Since then, he has been involved in the field of hematopoietic cell transplantation, and more recently of hematopoietic cellular therapies such as CAR-T Cells, with projects in translational and clinical research. He currently serves as Head and Qualified Person for the Cell Collection & Cell Processing Facility that serves several hematopoietic cell transplant and cellular therapy programs in the greater Marseille metropolitan area. Dr Chabannon is Board-certified in Hematology and Medical Oncology (France).
In 2005, he contributed to the creation of the “Centre d’Investigations Cliniques en Biothérapies » (CBT-1409) Inserm - Aix-Marseille Université – Institut Paoli-Calmettes – Assistance Publique des Hôpitaux de Marseille, of which he has been the scientific coordinator since then, thus promoting the development of biotherapeutic approaches with the metropolitan medical community.
As part of his scientific activities, he also created a unified and institutional biobank within the Comprehensive Cancer Center and affiliated research departments, to support internal and external scientific projects. In 2007, he was nominated as Professor of Cell Biology at Aix-Marseille Université School of Medicine. Docteur Chabannon was the Executive Director of “Cancéropôle PACA”, the Regional District Cancer Research Council. 2010 - 2015
Dr Chabannon has served on numerous national and international boards and advisory committees. In particular he was a member of the board of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). He has held several positions within the European society for Blood & Marrow Transplantation, (EBMT) including Chair of the JACIE Executive Committee (2008-2012), a unique initiative that promotes the introduction of quality management systems in medical practices and biomedical sciences, Chair of the Cell Processing Committee (2012-2014), and Secretary (2014-2018) then Chair of the Cellular Therapy & Immunobiology Working Party (CTIWP); he is currently board member and Vice-Chair of the Scientific Council with the portfolio for research activities.
Dr Chabannon played an active role in the emergence of ESBB. He is a founding member and acted as the local organizer for the inaugural ESBB Annual Meeting, held in Marseille, France in 2011. He acted as Secretary from 2014 through 2017 and is proud that he has recently been nominated as an ESBB Ambassador.